NMM
VRTX icon

Naples Money Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Naples Money Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13K Hold
28
– – 0.01% 159
2024
Q2 		$13.2K Hold
28
– – 0.01% 160
2024
Q1 		$11.7K Hold
28
– – 0.01% 185
2023
Q4 		$11.4K Buy
+28
New +$10.3K 0.01% 183

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Naples Money Management's VRTX Position: Q3 2024 in Review

Naples Money Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2024 at 28 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #159.

Naples Money Management first reported a position in VRTX in Q4 2023 and has held it in 4 quarters since. The position peaked at $13.2K in Q2 2024. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • Naples Money Management held 28 shares of Vertex Pharmaceuticals worth $13K as of Q3 2024.
  • Naples Money Management left its Vertex Pharmaceuticals share count unchanged in Q3 2024.
  • Vertex Pharmaceuticals made up 0.01% of Naples Money Management's portfolio in Q3 2024, its #159 holding.
  • Naples Money Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Naples Money Management's Vertex Pharmaceuticals position peaked at $13.2K in Q2 2024.
  • 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.